Filling the gap in mental health research Ways to tackle the lack of funding in mental health research.…
Malaria vaccine inefficiency explained by researchers Genetic variation in the parasite that causes malaria may explain why a vaccine developed against the disease has only moderate efficacy.…
Short and sharp radiotherapy as effective as standard radiotherapy for prostate cancer An international study found that giving patients higher but fewer doses of radiotherapy was as effective as standard radiotherapy for prostate cancer.…
Developing new psoriasis treatment regimens for patients based on their clinical profile Biologics and small-molecule drugs being developed to treat psoriasis are showing encouraging results, but high costs could limit their use.…
Placebos: more than meets the eye Often dismissed as fakes, placebos seem to work on the same brain pathways targeted by ‘real’ treatments and involve a complex network of genes.…
Asthma therapies get personal A new crop of biologic drugs promises to usher asthma treatment into the realm of personalised medicine.…
Closing in on Alzheimer’s disease Knowledge about the neuropathology of Alzheimer’s disease has blossomed over the past few decades, leading to a better understanding of the condition and new ways to attack it.…
Attacking cancer: are therapeutic vaccines on the verge of fulfilling their potential? Researchers are investigating whether priming the immune system with therapeutic vaccines can prompt the body’s own defences to spring into action against cancer.…
NICE’s assessment process is stifling pharmaceutical innovation The way new medicines are assessed should be reformed to provide patients with the best treatments and stimulate research and innovation in the UK.…
Nivolumab plus ipilimumab increases progression-free survival for melanoma patients Nivolumab alone or combined with ipilimumab results in longer progression-free survival than ipilimumab alone in patients with previously untreated metastatic melanoma.…